Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 121–132 of 134 articles · Explore study findings

Clear search and filters

  • Explore study findings

    Why the earlier MASH trial examined liver tissue directly

    Survodutide is an investigational peptide with activity at the glucagon and GLP-1 receptors. The older direct study for the biopsy question was a phase 2 trial in adults with confirmed metabolic dysfunction-associated steatohepatitis, or MASH, and varying degrees of scarring.

    Survodutide2 sources (2024, 2026)

  • Explore study findings

    Why a two-amino-acid breakdown product drew attention in 2026

    TB-500 is used here for the acetylated seven-amino-acid fragment corresponding to part of thymosin beta-4. A 2026 study asked whether a smaller molecule made during its breakdown could explain some effects attributed to the parent peptide.

    TB-5002 sources (2024, 2026)

  • Explore study findings

    What a rat Achilles study reported for its TB-500 group

    TB-500 commonly refers to a synthetic acetylated fragment of thymosin beta-4 made from seven amino acids. A July 2026 rat experiment used a reagent labeled TB-500 after surgical repair of the Achilles tendon.

    TB-5002 sources (2012, 2026)

  • Explore study findings

    Which molecule the 2026 HHS policy calls TB-500

    Department of Health and Human Services defined TB-500 acetate as the acetate form of an N-acetylated seven-amino-acid fragment of thymosin beta-4. The policy makes the chemical identity explicit because names used for research products can be ambiguous.

    TB-5003 sources (2026)

  • Explore study findings

    What a randomized extension showed when participants switched to placebo

    Tesamorelin is a 44-residue growth hormone–releasing hormone analogue with an added chemical group at its starting end. An older clinical trial used a second randomized phase to ask what happened to abdominal visceral fat when participants continued the study treatment or switched to placebo.

    Tesamorelin2 sources (2010, 2026)

  • Explore study findings

    What a Large Sepsis Trial Found About Thymosin Alpha 1

    Thymosin alpha-1 is a 28-amino-acid peptide studied in immune regulation, and thymalfasin is a drug form of it. The phase 3 TESTS trial asked whether adding thymosin alpha-1 to the care of adults with sepsis reduced death within 28 days.

    Thymosin Alpha-13 sources (2025, 2026)

  • Explore study findings

    What the lowest recorded weight adds to a three-year analysis

    Tirzepatide acts at GIP and GLP-1 receptors. The “TIRZ GLP-2” catalog wording refers to tirzepatide rather than the GLP-2 receptor. A 2026 analysis explored how much weight participants regained from their lowest recorded weight while they remained in a long-term study.

    TIRZ GLP-22 sources (2022, 2026)

  • Explore study findings

    What researchers observed after tirzepatide withdrawal

    Tirzepatide is a GIP and GLP-1 receptor agonist peptide. The “TIRZ GLP-2” label identifies the catalog entry. In a later analysis of SURMOUNT-4, researchers examined how weight regain after withdrawal related to changes in blood pressure, waist circumference and other measures.

    TIRZ GLP-22 sources (2022, 2025)

  • Explore study findings

    What a myostatin antibody study tells us about its own target

    Tirzepatide is a peptide that activates the GIP and GLP-1 receptors. IGF-1 LR3 is an engineered, extended insulin-like growth factor protein. A 2026 trial added a different molecule to tirzepatide, the antibody apitegromab.

    TIRZ / IGF-1 LR33 sources (1992, 2026)

  • Explore study findings

    The prostate cancer trial that holds triptorelin constant

    Triptorelin is a synthetic ten-amino-acid version of gonadotropin-releasing hormone, or GnRH. With sustained exposure it lowers testosterone, and the U.S. prescribing label for Trelstar identifies advanced prostate cancer as its approved use.

    Triptorelin GnRH2 sources (2026)

  • Explore study findings

    What changed when an IVF trial added triptorelin to hCG?

    Triptorelin acetate contains a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH.

    Triptorelin GnRH3 sources (2025, 2026)

  • Explore study findings

    What longer follow-up adds to triptorelin research in early puberty

    Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. An extended-release U.S. product, Triptodur, is approved for central precocious puberty in children age two and older.

    Triptorelin GnRH2 sources (2025, 2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)